Last update:

Urology news

Team targets the spinal cord to solve paralysis' most overlooked problem

Approximately 308,000 people in the United States live with spinal cord injury. Nearly all lose bladder control. And yet the vast majority of research and engineering attention in neurotech has poured into motor restoration—making ...

Tumor bacteria inspire peptide that starves prostate cancer cells in preclinical tests

Researchers at the University of Illinois Chicago have developed an anti-cancer therapy inspired by bacteria found in cancer tumors. When tested in combination with radiation in animal models of prostate cancer, it was highly ...

Erectile disorder: How science is moving beyond Viagra

Erectile disorder (ED) refers to a persistent difficulty achieving or maintaining an erection sufficient for satisfying sexual activity. It affects millions of men worldwide, including up to 1 in 4 in the United States. Beyond ...

Can the pill be side-effect free and taken on demand?

Preventing pregnancy is largely viewed as the responsibility of anyone who can become pregnant. It's a burden that can hold significant emotional, financial and physical weight (not just the bathroom scale kind).

A big step toward safe, reversible male contraception

Cornell scientists have taken a major step toward developing a safe, reversible, long-acting and 100% effective nonhormonal male contraceptive, considered the holy grail of male contraception. A proof-of-principle study in ...

HRT patches to treat prostate cancer—here's how it works

Women's HRT patches can treat prostate cancer just as effectively as standard hormone injections—but with fewer of the worst side effects—according to a large UK trial published in the New England Journal of Medicine. The ...

FDA warns biotech firm over cancer drug claims

The U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.

Should I worry about testicular cancer?

One in every 250 men will develop testicular cancer in their lifetime, and the numbers are increasing. The good news: It's very treatable if caught early and treated correctly.

Clinical trial targets kidney cancer with internal radiation

Researchers at London Health Sciences Center Research Institute (LHSCRI) have launched a Phase II clinical trial that aims to treat renal cell carcinoma (kidney cancer) by inserting microscopic beads filled with radiation ...

Advice on getting screened for prostate cancer

The importance of all health screenings is that they can detect issues early. Prostate cancer is one of the most common cancers in the world, and the second-leading cause of cancer deaths among men in the U.S.